287 related articles for article (PubMed ID: 7731155)
1. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study.
Rudnick MR; Goldfarb S; Wexler L; Ludbrook PA; Murphy MJ; Halpern EF; Hill JA; Winniford M; Cohen MB; VanFossen DB
Kidney Int; 1995 Jan; 47(1):254-61. PubMed ID: 7731155
[TBL] [Abstract][Full Text] [Related]
2. Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The Iohexol Cooperative Study.
Hill JA; Winniford M; Cohen MB; Van Fossen DB; Murphy MJ; Halpern EF; Ludbrook PA; Wexler L; Rudnick MR; Goldfarb S
Am J Cardiol; 1993 Oct; 72(11):770-5. PubMed ID: 8213508
[TBL] [Abstract][Full Text] [Related]
3. A comparison of iohexol and diatrizoate-meglumine in children undergoing cardiac catheterization.
Pelech AN; Allard SM; Hurd RT; Giddins NG; Collins GF
Invest Radiol; 1991 Jul; 26(7):665-70. PubMed ID: 1885274
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized trial of iohexol 350 versus meglumine sodium diatrizoate as an oral contrast agent for abdominopelvic computed tomography.
Peterson CM; Lin M; Pilgram T; Heiken JP
J Comput Assist Tomogr; 2011; 35(2):202-5. PubMed ID: 21412090
[TBL] [Abstract][Full Text] [Related]
5. Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial.
Moore RD; Steinberg EP; Powe NR; Brinker JA; Fishman EK; Graziano S; Gopalan R
Radiology; 1992 Mar; 182(3):649-55. PubMed ID: 1535876
[TBL] [Abstract][Full Text] [Related]
6. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
[TBL] [Abstract][Full Text] [Related]
7. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent.
Schwab SJ; Hlatky MA; Pieper KS; Davidson CJ; Morris KG; Skelton TN; Bashore TM
N Engl J Med; 1989 Jan; 320(3):149-53. PubMed ID: 2643042
[TBL] [Abstract][Full Text] [Related]
8. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography.
Taliercio CP; Vlietstra RE; Ilstrup DM; Burnett JC; Menke KK; Stensrud SL; Holmes DR
J Am Coll Cardiol; 1991 Feb; 17(2):384-90. PubMed ID: 1991894
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study on nephrotoxicity of ionic and non-ionic contrast agents for drip infused urography].
Sugaya K; Nishizawa O; Noto H; Suzuki T; Shimoda N; Miyagata S; Harada T; Tsuchida S
Hinyokika Kiyo; 1992 Jul; 38(7):767-73. PubMed ID: 1524001
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the rates of adverse drug reactions. Ionic contrast agents, ionic agents combined with steroids, and nonionic agents.
Wolf GL; Mishkin MM; Roux SG; Halpern EF; Gottlieb J; Zimmerman J; Gillen J; Thellman C
Invest Radiol; 1991 May; 26(5):404-10. PubMed ID: 2055736
[TBL] [Abstract][Full Text] [Related]
11. Comparison of iohexol 300 and diatrizoate meglumine 60 for body CT: image quality, adverse reactions, and aborted/repeated examinations.
Bernardino ME; Fishman EK; Jeffrey RB; Brown PC
AJR Am J Roentgenol; 1992 Mar; 158(3):665-7. PubMed ID: 1739017
[TBL] [Abstract][Full Text] [Related]
12. Radiocontrast nephropathy: is it dose related or not?
Mekan SF; Rabbani MA; Azhar-uddin M; Ali SS
J Pak Med Assoc; 2004 Jul; 54(7):372-4. PubMed ID: 15449920
[TBL] [Abstract][Full Text] [Related]
13. The use of iohexol in pediatric urography: a comparative study with meglumine diatrizoate.
Bani E; Federighi F; Ghio R; Marchitiello M; Galigani P; Palla R
Int J Pediatr Nephrol; 1985; 6(4):271-4. PubMed ID: 4093245
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the nephrotoxicity of iohexol, iopamidol and ioxaglate in peripheral angiography.
Campbell DR; Flemming BK; Mason WF; Jackson SA; Hirsch DJ; MacDonald KJ
Can Assoc Radiol J; 1990 Jun; 41(3):133-7. PubMed ID: 2354386
[TBL] [Abstract][Full Text] [Related]
15. Comparison of patient reactions and diagnostic quality for hysterosalpingography using ionic and nonionic contrast media.
Chen MY; Zagoria RJ; Fayez JA; Ott DJ; Van Swearingen FL
Acad Radiol; 1995 Feb; 2(2):123-7. PubMed ID: 9419535
[TBL] [Abstract][Full Text] [Related]
16. A comparison of low- with high-osmolality contrast agents in cardiac angiography. Identification of criteria for selective use.
Matthai WH; Kussmaul WG; Krol J; Goin JE; Schwartz JS; Hirshfeld JW
Circulation; 1994 Jan; 89(1):291-301. PubMed ID: 8281660
[TBL] [Abstract][Full Text] [Related]
17. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease.
Toprak O; Cirit M; Yesil M; Bayata S; Tanrisev M; Varol U; Ersoy R; Esi E
Nephrol Dial Transplant; 2007 Mar; 22(3):819-26. PubMed ID: 17090607
[TBL] [Abstract][Full Text] [Related]
18. Nephrotoxicity of nonionic contrast media after cardiac angiography.
Taliercio CP; McCallister SH; Holmes DR; Ilstrup DM; Vlietstra RE
Am J Cardiol; 1989 Oct; 64(12):815-6. PubMed ID: 2801538
[No Abstract] [Full Text] [Related]
19. Renal effects and nephrotoxicity of contrast media in renal patients.
Donadio C; Tramonti G; Giordani R; Lucchetti A; Calderazzi A; Ferrari P; Bianchi C
Contrib Nephrol; 1993; 101():241-50. PubMed ID: 8467681
[No Abstract] [Full Text] [Related]
20. Iohexol cerebral angiography. Multicenter clinical trial.
Kido DK; Potts DG; Bryan RN; Norman D; Pelz DM; Fox AJ; Shaw DD
Invest Radiol; 1985; 20(1 Suppl):S55-7. PubMed ID: 3882617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
